Apollon Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Apollon Wealth Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.88M	Buy	+137,661	New	+$7.54M	0.1%	189

Other funds holding BMRN

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Covea Finance Paris, France $3.17B AUM 35.01% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

SAM

Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return

Apollon Wealth Management's BMRN Position: Q2 2026 in Review

Apollon Wealth Management opened a new position in BioMarin Pharmaceuticals (BMRN) in Q2 2026: 137,661 shares worth $7.88M. The stake represents 0.1% of the portfolio and ranks #189 among its holdings.

88 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Apollon Wealth Management held 137,661 shares of BioMarin Pharmaceuticals worth $7.88M as of Q2 2026.
BioMarin Pharmaceuticals was a new Apollon Wealth Management position in Q2 2026.
BioMarin Pharmaceuticals made up 0.1% of Apollon Wealth Management's portfolio in Q2 2026, its #189 holding.
88 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.